Medical Care
Global Latent Tuberculosis Infection (LTBI) Testing Market Research Report 2025
- Apr 16, 25
- ID: 192751
- Pages: 77
- Figures: 78
- Views: 2
The global market for Latent Tuberculosis Infection (LTBI) Testing was valued at US$ 1550 million in the year 2024 and is projected to reach a revised size of US$ 2228 million by 2031, growing at a CAGR of 5.4% during the forecast period.
The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc.
Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.
The detection industry of latent tuberculosis infection (LTBI) can be subdivided into several parts: tuberculin skin test (TST), interferon release test (IGRA), etc.
Globally, there are mainly Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis infection (LTBI) is an important strategy recognized by the World Health Organization to accelerate the decline of global tuberculosis and achieve the elimination of tuberculosis. Latent tuberculosis infection (LTBI) refers to the state of continuous immune response to the stimulation of Mycobacterium tuberculosis antigen in the absence of clinical evidence of active tuberculosis (TB). The diagnosis and treatment of long-term tuberculosis is very important for tuberculosis, especially for high-risk groups. Tuberculin skin tests (TST) and interferon release tests (IGRAs) were used to diagnose LTBI.
This report aims to provide a comprehensive presentation of the global market for Latent Tuberculosis Infection (LTBI) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Latent Tuberculosis Infection (LTBI) Testing.
The Latent Tuberculosis Infection (LTBI) Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Latent Tuberculosis Infection (LTBI) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Latent Tuberculosis Infection (LTBI) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qiagen
Sanofi
Oxford Immunotec
Thermo Fisher Scientific
Par Sterile
Bio-Rad Laboratories
Segment by Type
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Segment by Application
Hospitals and Clinics
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Latent Tuberculosis Infection (LTBI) Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc.
Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.
The detection industry of latent tuberculosis infection (LTBI) can be subdivided into several parts: tuberculin skin test (TST), interferon release test (IGRA), etc.
Globally, there are mainly Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis infection (LTBI) is an important strategy recognized by the World Health Organization to accelerate the decline of global tuberculosis and achieve the elimination of tuberculosis. Latent tuberculosis infection (LTBI) refers to the state of continuous immune response to the stimulation of Mycobacterium tuberculosis antigen in the absence of clinical evidence of active tuberculosis (TB). The diagnosis and treatment of long-term tuberculosis is very important for tuberculosis, especially for high-risk groups. Tuberculin skin tests (TST) and interferon release tests (IGRAs) were used to diagnose LTBI.
This report aims to provide a comprehensive presentation of the global market for Latent Tuberculosis Infection (LTBI) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Latent Tuberculosis Infection (LTBI) Testing.
The Latent Tuberculosis Infection (LTBI) Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Latent Tuberculosis Infection (LTBI) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Latent Tuberculosis Infection (LTBI) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qiagen
Sanofi
Oxford Immunotec
Thermo Fisher Scientific
Par Sterile
Bio-Rad Laboratories
Segment by Type
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Segment by Application
Hospitals and Clinics
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Latent Tuberculosis Infection (LTBI) Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tuberculin Skin Test (TST)
1.2.3 Interferon Gamma Released Assay (IGRA)
1.3 Market by Application
1.3.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Perspective (2020-2031)
2.2 Global Latent Tuberculosis Infection (LTBI) Testing Growth Trends by Region
2.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Region (2020-2025)
2.2.3 Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Region (2026-2031)
2.3 Latent Tuberculosis Infection (LTBI) Testing Market Dynamics
2.3.1 Latent Tuberculosis Infection (LTBI) Testing Industry Trends
2.3.2 Latent Tuberculosis Infection (LTBI) Testing Market Drivers
2.3.3 Latent Tuberculosis Infection (LTBI) Testing Market Challenges
2.3.4 Latent Tuberculosis Infection (LTBI) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Revenue
3.1.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Revenue (2020-2025)
3.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Players (2020-2025)
3.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Latent Tuberculosis Infection (LTBI) Testing Revenue
3.4 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio
3.4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2024
3.5 Global Key Players of Latent Tuberculosis Infection (LTBI) Testing Head office and Area Served
3.6 Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Product and Application
3.7 Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Latent Tuberculosis Infection (LTBI) Testing Breakdown Data by Type
4.1 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Type (2020-2025)
4.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Type (2026-2031)
5 Latent Tuberculosis Infection (LTBI) Testing Breakdown Data by Application
5.1 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Application (2020-2025)
5.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size (2020-2031)
6.2 North America Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025)
6.4 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size (2020-2031)
7.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025)
7.4 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size (2020-2031)
8.2 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size (2020-2031)
9.2 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025)
9.4 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size (2020-2031)
10.2 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qiagen
11.1.1 Qiagen Company Details
11.1.2 Qiagen Business Overview
11.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Introduction
11.1.4 Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
11.1.5 Qiagen Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Introduction
11.2.4 Sanofi Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
11.2.5 Sanofi Recent Development
11.3 Oxford Immunotec
11.3.1 Oxford Immunotec Company Details
11.3.2 Oxford Immunotec Business Overview
11.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Introduction
11.3.4 Oxford Immunotec Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
11.3.5 Oxford Immunotec Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Par Sterile
11.5.1 Par Sterile Company Details
11.5.2 Par Sterile Business Overview
11.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Introduction
11.5.4 Par Sterile Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
11.5.5 Par Sterile Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Introduction
11.6.4 Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
11.6.5 Bio-Rad Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tuberculin Skin Test (TST)
1.2.3 Interferon Gamma Released Assay (IGRA)
1.3 Market by Application
1.3.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Perspective (2020-2031)
2.2 Global Latent Tuberculosis Infection (LTBI) Testing Growth Trends by Region
2.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Region (2020-2025)
2.2.3 Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Region (2026-2031)
2.3 Latent Tuberculosis Infection (LTBI) Testing Market Dynamics
2.3.1 Latent Tuberculosis Infection (LTBI) Testing Industry Trends
2.3.2 Latent Tuberculosis Infection (LTBI) Testing Market Drivers
2.3.3 Latent Tuberculosis Infection (LTBI) Testing Market Challenges
2.3.4 Latent Tuberculosis Infection (LTBI) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Revenue
3.1.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Revenue (2020-2025)
3.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Players (2020-2025)
3.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Latent Tuberculosis Infection (LTBI) Testing Revenue
3.4 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio
3.4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2024
3.5 Global Key Players of Latent Tuberculosis Infection (LTBI) Testing Head office and Area Served
3.6 Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Product and Application
3.7 Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Latent Tuberculosis Infection (LTBI) Testing Breakdown Data by Type
4.1 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Type (2020-2025)
4.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Type (2026-2031)
5 Latent Tuberculosis Infection (LTBI) Testing Breakdown Data by Application
5.1 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Application (2020-2025)
5.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size (2020-2031)
6.2 North America Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025)
6.4 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size (2020-2031)
7.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025)
7.4 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size (2020-2031)
8.2 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size (2020-2031)
9.2 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025)
9.4 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size (2020-2031)
10.2 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qiagen
11.1.1 Qiagen Company Details
11.1.2 Qiagen Business Overview
11.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Introduction
11.1.4 Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
11.1.5 Qiagen Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Introduction
11.2.4 Sanofi Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
11.2.5 Sanofi Recent Development
11.3 Oxford Immunotec
11.3.1 Oxford Immunotec Company Details
11.3.2 Oxford Immunotec Business Overview
11.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Introduction
11.3.4 Oxford Immunotec Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
11.3.5 Oxford Immunotec Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Par Sterile
11.5.1 Par Sterile Company Details
11.5.2 Par Sterile Business Overview
11.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Introduction
11.5.4 Par Sterile Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
11.5.5 Par Sterile Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Introduction
11.6.4 Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
11.6.5 Bio-Rad Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Tuberculin Skin Test (TST)
Table 3. Key Players of Interferon Gamma Released Assay (IGRA)
Table 4. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Region (2020-2025)
Table 8. Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Region (2026-2031)
Table 10. Latent Tuberculosis Infection (LTBI) Testing Market Trends
Table 11. Latent Tuberculosis Infection (LTBI) Testing Market Drivers
Table 12. Latent Tuberculosis Infection (LTBI) Testing Market Challenges
Table 13. Latent Tuberculosis Infection (LTBI) Testing Market Restraints
Table 14. Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Players (2020-2025)
Table 16. Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent Tuberculosis Infection (LTBI) Testing as of 2024)
Table 17. Ranking of Global Top Latent Tuberculosis Infection (LTBI) Testing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Latent Tuberculosis Infection (LTBI) Testing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Headquarters and Area Served
Table 20. Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Product and Application
Table 21. Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type (2020-2025)
Table 25. Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type (2026-2031)
Table 27. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application (2020-2025)
Table 29. Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application (2026-2031)
Table 31. North America Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Qiagen Company Details
Table 47. Qiagen Business Overview
Table 48. Qiagen Latent Tuberculosis Infection (LTBI) Testing Product
Table 49. Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 50. Qiagen Recent Development
Table 51. Sanofi Company Details
Table 52. Sanofi Business Overview
Table 53. Sanofi Latent Tuberculosis Infection (LTBI) Testing Product
Table 54. Sanofi Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 55. Sanofi Recent Development
Table 56. Oxford Immunotec Company Details
Table 57. Oxford Immunotec Business Overview
Table 58. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product
Table 59. Oxford Immunotec Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 60. Oxford Immunotec Recent Development
Table 61. Thermo Fisher Scientific Company Details
Table 62. Thermo Fisher Scientific Business Overview
Table 63. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product
Table 64. Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 65. Thermo Fisher Scientific Recent Development
Table 66. Par Sterile Company Details
Table 67. Par Sterile Business Overview
Table 68. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product
Table 69. Par Sterile Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 70. Par Sterile Recent Development
Table 71. Bio-Rad Laboratories Company Details
Table 72. Bio-Rad Laboratories Business Overview
Table 73. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product
Table 74. Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 75. Bio-Rad Laboratories Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
Table 79. Authors List of This Report
List of Figures
Figure 1. Latent Tuberculosis Infection (LTBI) Testing Picture
Figure 2. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Type: 2024 VS 2031
Figure 4. Tuberculin Skin Test (TST) Features
Figure 5. Interferon Gamma Released Assay (IGRA) Features
Figure 6. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application: 2024 VS 2031
Figure 8. Hospitals and Clinics Case Studies
Figure 9. Diagnostic Laboratories Case Studies
Figure 10. Others Case Studies
Figure 11. Latent Tuberculosis Infection (LTBI) Testing Report Years Considered
Figure 12. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Latent Tuberculosis Infection (LTBI) Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Region: 2024 VS 2031
Figure 15. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Players in 2024
Figure 16. Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent Tuberculosis Infection (LTBI) Testing as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2024
Figure 18. North America Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2020-2031)
Figure 20. United States Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2020-2031)
Figure 24. Germany Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Share by Region (2020-2031)
Figure 32. China Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2020-2031)
Figure 40. Mexico Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2020-2031)
Figure 44. Turkey Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Qiagen Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 48. Sanofi Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 49. Oxford Immunotec Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 51. Par Sterile Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 52. Bio-Rad Laboratories Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Table 1. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Tuberculin Skin Test (TST)
Table 3. Key Players of Interferon Gamma Released Assay (IGRA)
Table 4. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Region (2020-2025)
Table 8. Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Region (2026-2031)
Table 10. Latent Tuberculosis Infection (LTBI) Testing Market Trends
Table 11. Latent Tuberculosis Infection (LTBI) Testing Market Drivers
Table 12. Latent Tuberculosis Infection (LTBI) Testing Market Challenges
Table 13. Latent Tuberculosis Infection (LTBI) Testing Market Restraints
Table 14. Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Players (2020-2025)
Table 16. Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent Tuberculosis Infection (LTBI) Testing as of 2024)
Table 17. Ranking of Global Top Latent Tuberculosis Infection (LTBI) Testing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Latent Tuberculosis Infection (LTBI) Testing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Headquarters and Area Served
Table 20. Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Product and Application
Table 21. Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type (2020-2025)
Table 25. Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type (2026-2031)
Table 27. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application (2020-2025)
Table 29. Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application (2026-2031)
Table 31. North America Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Qiagen Company Details
Table 47. Qiagen Business Overview
Table 48. Qiagen Latent Tuberculosis Infection (LTBI) Testing Product
Table 49. Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 50. Qiagen Recent Development
Table 51. Sanofi Company Details
Table 52. Sanofi Business Overview
Table 53. Sanofi Latent Tuberculosis Infection (LTBI) Testing Product
Table 54. Sanofi Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 55. Sanofi Recent Development
Table 56. Oxford Immunotec Company Details
Table 57. Oxford Immunotec Business Overview
Table 58. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product
Table 59. Oxford Immunotec Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 60. Oxford Immunotec Recent Development
Table 61. Thermo Fisher Scientific Company Details
Table 62. Thermo Fisher Scientific Business Overview
Table 63. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product
Table 64. Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 65. Thermo Fisher Scientific Recent Development
Table 66. Par Sterile Company Details
Table 67. Par Sterile Business Overview
Table 68. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product
Table 69. Par Sterile Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 70. Par Sterile Recent Development
Table 71. Bio-Rad Laboratories Company Details
Table 72. Bio-Rad Laboratories Business Overview
Table 73. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product
Table 74. Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 75. Bio-Rad Laboratories Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
Table 79. Authors List of This Report
List of Figures
Figure 1. Latent Tuberculosis Infection (LTBI) Testing Picture
Figure 2. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Type: 2024 VS 2031
Figure 4. Tuberculin Skin Test (TST) Features
Figure 5. Interferon Gamma Released Assay (IGRA) Features
Figure 6. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application: 2024 VS 2031
Figure 8. Hospitals and Clinics Case Studies
Figure 9. Diagnostic Laboratories Case Studies
Figure 10. Others Case Studies
Figure 11. Latent Tuberculosis Infection (LTBI) Testing Report Years Considered
Figure 12. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Latent Tuberculosis Infection (LTBI) Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Region: 2024 VS 2031
Figure 15. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Players in 2024
Figure 16. Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent Tuberculosis Infection (LTBI) Testing as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2024
Figure 18. North America Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2020-2031)
Figure 20. United States Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2020-2031)
Figure 24. Germany Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Share by Region (2020-2031)
Figure 32. China Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2020-2031)
Figure 40. Mexico Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2020-2031)
Figure 44. Turkey Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Qiagen Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 48. Sanofi Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 49. Oxford Immunotec Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 51. Par Sterile Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 52. Bio-Rad Laboratories Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232